IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Investor Presentation
Q4 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q4 FY25
Investor Presentation
Q4 FY25
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
9.60 | 24 Cr | 471.60 | 1.98 | 0.00 | 0.42 | 2.93 | 0.10 | ||
4.10 | 21 Cr | -8.30 | 0.00 | 0.00 | -88.60 | -12.91 | -6.06 | ||
46.01 | 21 Cr | 50.38 | 3.22 | 0.00 | 26.76 | 18.25 | 2.46 | ||
48.71 | 21 Cr | 6.01 | 0.56 | 0.00 | 9.33 | 12.53 | 8.49 | ||
6.54 | 19 Cr | -239.75 | 1.84 | 0.00 | 1.65 | 2.16 | 2.26 | ||
29.55 | 19 Cr | -185.30 | 1.91 | 0.00 | 2.53 | 2.56 | 2.86 | ||
31.35 | 18 Cr | -108.65 | 38.73 | 0.00 | -41.50 | -2.16 | -2.02 | ||
| Median: 7 Co. | — | 29.55 | 21 Cr | -8.30 | 1.91 | 0.00 | 1.65 | 2.56 | 2.26 |
Bearish
4
Neutral
8
Bullish
2
Bearish
25
Neutral
12
Bullish
9
Bearish
21
Neutral
4
Bullish
7
Bearish
21
Neutral
4
Bullish
7
Bearish
21
Neutral
4
Bullish
7
Bearish
21
Neutral
4
Bullish
7
Upcoming Result Date: Today
Caprolactam Chemicals Ltd (CAPRO) is currently trading at 46.01 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Caprolactam Chemicals Limited is a Mumbai‑registered specialty chemical manufacturer and contract manufacturing provider operating a state‑of‑the‑art plant at Mahad, Maharashtra; it offers ready‑to‑use facilities and job‑work services for flavours & fragrance, aroma, pharma and agrochemical companies and positions itself as a fast commercialization partner for customers without infrastructure investment. The company reported a fiscal 2025‑26 revenue of approximately Rs. 1,058.86 lakhs and a profit after tax of Rs. 176.12 lakhs, representing a clear financial turnaround from the prior year loss; basic and diluted EPS for the year were Rs. 3.83, and the statutory auditor issued an unmodified opinion on the audited results. Balance sheet and cash‑flow movements show total assets of about Rs. 1,703.96 lakhs, equity of Rs. 658.16 lakhs and borrowings around Rs. 922.90 lakhs; operating cash generation for the year was positive (net cash from operations ~Rs. 164.97 lakhs) while cash and cash equivalents remain modest at about Rs. 8.69 lakhs. Management approved a modest capex during the year (purchase of property, plant and equipment of ~Rs. 146.78 lakhs) and appointed M/s. Shrey Pandey & Associates as internal auditor for FY2026‑27, indicating an emphasis on governance, operational investment and strengthening internal controls after the return to profitability.
Over the past 52 weeks, Caprolactam Chemicals Ltd has traded between a low of ₹37.10 and a high of ₹81.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Caprolactam Chemicals Ltd has a market capitalization of approximately 21.16. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Caprolactam Chemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 50.38 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 21.16 Cr, Caprolactam Chemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Caprolactam Chemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Caprolactam Chemicals Ltd is 50.38. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Caprolactam Chemicals Limited is a Mumbai‑registered specialty chemical manufacturer and contract manufacturing provider operating a state‑of‑the‑art plant at Mahad, Maharashtra; it offers ready‑to‑use facilities and job‑work services for flavours & fragrance, aroma, pharma and agrochemical companies and positions itself as a fast commercialization partner for customers without infrastructure investment.
The company reported a fiscal 2025‑26 revenue of approximately Rs. 1,058.86 lakhs and a profit after tax of Rs. 176.12 lakhs, representing a clear financial turnaround from the prior year loss; basic and diluted EPS for the year were Rs. 3.83, and the statutory auditor issued an unmodified opinion on the audited results.
Balance sheet and cash‑flow movements show total assets of about Rs. 1,703.96 lakhs, equity of Rs. 658.16 lakhs and borrowings around Rs. 922.90 lakhs; operating cash generation for the year was positive (net cash from operations ~Rs. 164.97 lakhs) while cash and cash equivalents remain modest at about Rs. 8.69 lakhs.
Management approved a modest capex during the year (purchase of property, plant and equipment of ~Rs. 146.78 lakhs) and appointed M/s. Shrey Pandey & Associates as internal auditor for FY2026‑27, indicating an emphasis on governance, operational investment and strengthening internal controls after the return to profitability.
Chemicals & Petrochemicals
Commodity Chemicals
21 Cr
Low Risk
50.4
34.6
0.1
3.2
81.00
37.10
Sales CAGR
Profit CAGR
ROE
ROCE
